Chancellor Rachel Reeves Plans Targeted Action on Bills in Upcoming Financial Plan

Chancellor Reeves has stated she is preparing "targeted steps to deal with cost of living pressures" in next month's Budget.

In comments to the BBC, she stated that lowering inflation is a collective responsibility of both the government and the central bank.

The UK's price growth is expected to be the highest among the Group of Seven industrialized countries this calendar year and the following year.

Possible Utility Bill Interventions

It is understood the government could take action to reduce utility costs, such as by reducing the current 5% level of value-added tax charged on energy.

A further possibility is to cut some of the government charges currently included in bills.

Fiscal Limitations and Analyst Expectations

The government will obtain the next assessment from the independent fiscal watchdog, the OBR, on the start of the week, which will show how much space there is for such measures.

The consensus from most economists is that Reeves will have to introduce tax rises or budget cuts in order to adhere to her self-imposed debt limits.

Earlier on Thursday, analysis suggested there was a £22bn deficit for the chancellor to address, which is at the lower end of projections.

"It is a joint responsibility between the Bank of England and the government to continue tackling some of the sources of price increases," the Chancellor told reporters in the US capital, at the annual meetings of the IMF and global financial institution.

Tax Pledges and International Issues

While much of the focus has been on probable tax rises, the chancellor said the latest data from the OBR had not changed her pledge to campaign commitments not to increase rates on earnings tax, VAT or social security contributions.

She attributed an "unpredictable global environment" with rising international and commercial issues for the Budget tax moves, likely to be directed on those "wealthiest."

Global Trade Tensions

Addressing worries about the UK's economic relations with China she said: "The UK's security interests invariably are paramount."

Last week's statement by Chinese authorities to increase trade restrictions on rare earths and other resources that are crucial for high-technology manufacturing led US President Donald Trump to propose an further 100% tariff on imports from the Asian country, increasing the risk of an full-scale commercial conflict between the two largest economies.

The American finance chief called China's move "economic coercion" and "a global supply chain control attempt."

Asked about considering the American proposal to join its battle with the Asian nation, the Chancellor said she was "extremely troubled" by Chinese actions and urged the Chinese government "to avoid restrictions and limit trade."

She said the decision was "damaging for the global economy and generates additional challenges."

"I believe there are areas where we should challenge Chinese policies, but there are also important chances to export to Chinese markets, including financial services and other areas of the economic system. We've got to maintain that equilibrium right."

The chancellor also confirmed she was cooperating with international partners "on our own essential resources approach, so that we are reduced dependence."

NHS Drug Costs and Funding

The Chancellor also acknowledged that the cost the National Health Service pays for medicines could rise as a result of ongoing discussions with the US government and its pharmaceutical firms, in exchange for lower tariffs and funding.

A number of the biggest global pharmaceutical manufacturers have said recently that they are either halting or canceling investments in the United Kingdom, with some attributing the modest returns they are obtaining.

Last month, the government science advisor said the price the NHS spends on medicines would have to rise to halt firms and drug research funding leaving the UK.

The Chancellor told media: "It has been observed due to the cost structure, that medical research, new drugs have not been provided in the United Kingdom in the manner that they are in other continental states."

"Our aim is to ensure that individuals getting treatment from the National Health Service are able to access the finest essential medicines in the globe. And so we are reviewing all of that, and... looking to obtain increased funding into Britain."